Related references
Note: Only part of the references are listed.Emerging therapeutic opportunities for integrin inhibitors
R. J. Slack et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
The role of integrins in inflammation and angiogenesis
Olachi J. Mezu-Ndubuisi et al.
PEDIATRIC RESEARCH (2021)
Smooth Muscle Cell-Specific PKM2 (Pyruvate Kinase Muscle 2) Promotes Smooth Muscle Cell Phenotypic Switching and Neointimal Hyperplasia
Manish Jain et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Focal adhesion signaling: vascular smooth muscle cell contractility beyond calcium mechanisms
J.C. Ribeiro-Silva et al.
CLINICAL SCIENCE (2021)
Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights
Shihan Xu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Integrins as attractive targets for cancer therapeutics
Meng Li et al.
ACTA PHARMACEUTICA SINICA B (2021)
Filamin A Regulates Cardiovascular Remodeling
Sashidar Bandaru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
Manish Jain et al.
JCI INSIGHT (2021)
Mechanisms of drug-eluting stent restenosis
Jiro Aoki et al.
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS (2021)
Smooth muscle cell-specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasia
Manish Jain et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Targeting myeloid-cell specific integrin α9β1 inhibits arterial thrombosis in mice
Nirav Dhanesha et al.
BLOOD (2020)
Differential Roles of Endothelial Cell-Derived and Smooth Muscle Cell-Derived Fibronectin Containing Extra Domain A in Early and Late Atherosclerosis
Prakash Doddapattar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Targeting Myeloid-Specific Integrin α9β1 Improves Short- and Long-Term Stroke Outcomes in Murine Models With Preexisting Comorbidities by Limiting Thrombosis and Inflammation
Nirav Dhanesha et al.
CIRCULATION RESEARCH (2020)
Extracellular matrix dynamics in vascular remodeling
Zihan Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
Integrin α9 is involved in the pathopoiesis of acute aortic dissection via mediating phenotype switch of vascular smooth muscle cell
Bi Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Integrin-targeted therapies branch out
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2020)
Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation
Vitaly Sorokin et al.
FRONTIERS IN IMMUNOLOGY (2020)
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial
Tsutomu Takeuchi et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Inhibition of Smooth Muscle Cell Proliferation and Migration by a Talin Modulator Attenuates Neointimal Formation after Femoral Arterial Injury
I-Rang Lim et al.
KOREAN CIRCULATION JOURNAL (2020)
Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis
Zhishan Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Restenosis of Drug-Eluting Stents A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review
Evan Shlofmitz et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
The role of α9ß1 integrin and its ligands in the development of autoimmune diseases
Shigeyuki Kon et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Smooth muscle cell fate and plasticity in atherosclerosis
Sima Allahverdian et al.
CARDIOVASCULAR RESEARCH (2018)
Deletion of Extra Domain A of Fibronectin Reduces Acute Myocardial Ischaemia/Reperfusion Injury in Hyperlipidaemic Mice by Limiting Thrombo-Inflammation
Mehul R. Chorawala et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Constitutive Activation of Integrin α9 Augments Self-Directed Hyperplastic and Proinflammatory Properties of Fibroblast-like Synoviocytes of Rheumatoid Arthritis
Takashi Emori et al.
JOURNAL OF IMMUNOLOGY (2017)
Integrins as Therapeutic Targets: Successes and Cancers
Sabine Raab-Westphal et al.
CANCERS (2017)
Gingerol Inhibits Serum-Induced Vascular Smooth Muscle Cell Proliferation and Injury-Induced Neointimal Hyperplasia by Suppressing p38 MAPK Activation
Manish Jain et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2016)
Effects of integrin α5β1 on the proliferation and migration of human aortic vascular smooth muscle cells
Yan Song et al.
MOLECULAR MEDICINE REPORTS (2016)
Involvement of Interleukin-1 Receptor-Associated Kinase-1 in Vascular Smooth Muscle Cell Proliferation and Neointimal Formation After Rat Carotid Injury
Manish Jain et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Under-expression of α8 integrin aggravates experimental atherosclerosis
Carlos Menendez-Castro et al.
JOURNAL OF PATHOLOGY (2015)
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis
Laura S. Shankman et al.
NATURE MEDICINE (2015)
α5β1 Integrin Signaling Mediates Oxidized Low-Density Lipoprotein-Induced Inflammation and Early Atherosclerosis
Arif Yurdagul et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Integrin Cytoplasmic Tail Interactions
Elizabeth M. Morse et al.
BIOCHEMISTRY (2014)
Vascular wall extracellular matrix proteins and vascular diseases
Junyan Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
The Integrin Ligand c(RGDf(NMe)Nal) Reduces Neointimal Hyperplasia in a Polymer-Free Drug-Eluting Stent System
Florian Rechenmacher et al.
CHEMMEDCHEM (2014)
Current Treatment of In-Stent Restenosis
Fernando Alfonso et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis
Gema Bolas et al.
TOXICON (2014)
Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells
Marlene A. Bunni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Two-Year Clinical Outcome After Abciximab-Coated Stent Implantation in Patients With Coronary Artery Disease
Sun Soo Kim et al.
CIRCULATION JOURNAL (2010)
Integrin α7β1 COMPels Smooth Muscle Cells to Maintain Their Quiescence
Elaine W. Raines et al.
CIRCULATION RESEARCH (2010)
Cartilage Oligomeric Matrix Protein Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells by Interacting With α7β1 Integrin
Li Wang et al.
CIRCULATION RESEARCH (2010)
Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by β3 integrin signaling
Manikandan Panchatcharam et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Effects of an Alpha-4 Integrin Inhibitor on Restenosis in a New Porcine Model Combining Endothelial Denudation and Stent Placement
Anne Braun et al.
PLOS ONE (2010)
Integrin α9β1 Unique signaling pathways reveal diverse biological roles
Shiv K. Gupta et al.
CELL ADHESION & MIGRATION (2010)
Integrin α9β1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase
Shiv K. Gupta et al.
JOURNAL OF CELL SCIENCE (2009)
Alterations in integrin expression modulates invasion of pancreatic cancer cells
Naomi Walsh et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Activation of the integrins α5β1 and αvβ3 and focal adhesion kinase (FAK) during arteriogenesis
Wei-Jun Cai et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Integrin linked kinase (ILK) expression and function in vascular smooth muscle cells
Bernard Ho et al.
CELL ADHESION & MIGRATION (2009)
α8 integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype
Ramin Zargham et al.
ATHEROSCLEROSIS (2007)
Loss of the α7 integrin promoted extracellular signal-regulated kinase activation and altered vascular remodeling
Jennifer V. Welser et al.
CIRCULATION RESEARCH (2007)
Integrin αvβ3 as a target in the prevention of neointimal hyperplasia
Taku Kokubo et al.
JOURNAL OF VASCULAR SURGERY (2007)
α8 Integrin expression is required for maintenance of the smooth muscle cell differentiated phenotype
Ramin Zargham et al.
CARDIOVASCULAR RESEARCH (2006)
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells
R Blindt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
βig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through αvβ5 integrin
Byung-Heon Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Genetic deletion or antibody blockade of α1β1 integrin induces a stable plaque phenotype in ApoE-/- mice
K Schapira et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
α8β1 integrin expression in the rat carotid artery:: involvement in smooth muscle cell migration and neointima formation
R Zargham et al.
CARDIOVASCULAR RESEARCH (2005)
Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice
K Yamamoto et al.
CARDIOVASCULAR RESEARCH (2005)
The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin α9β1
NE Vlahakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Platelet-derived growth factor-BB modulates membrane mobility of β1 integrins
K Åhlén et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The spatial and temporal expression patterns of integrin α9β1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing
P Singh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
alpha(4)beta(1) integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) mice
KG Barringhaus et al.
JOURNAL OF VASCULAR RESEARCH (2004)
Integrins as unique receptors for vascular control
LA Martinez-Lemus et al.
JOURNAL OF VASCULAR RESEARCH (2003)
alpha(2)beta(1) integrin and development of atherosclerosis in a mouse model - Assessment of risk
DG Grenache et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Osteopontin plays an important role in the development of medial thickening and neointimal formation
K Isoda et al.
CIRCULATION RESEARCH (2002)
The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing
YF Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines
L Moro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation
P Dufourcq et al.
CARDIOVASCULAR RESEARCH (2002)
Integrin and growth factor receptor crosstalk
BP Eliceiri
CIRCULATION RESEARCH (2001)
Mechanisms in the inhibition of neointimal hyperplasia with triflavin in a rat model of balloon angioplasty
JR Sheu et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis
JH Baron et al.
CARDIOVASCULAR RESEARCH (2000)
Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin α9ß1 with VCAM-1, tenascin-C, and osteopontin
C Marcinkiewicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Smooth muscle cell matrix metalloproteinase production is stimulated via αvβ3 integrin
MP Bendeck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
α5β1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury
JG Pickering et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction
K Mawatari et al.
JOURNAL OF VASCULAR SURGERY (2000)
Share Paper
